732 related articles for article (PubMed ID: 24657569)
21. Synthesis and anticancer activity of some pyrido[2,3-
Abbas SE; George RF; Samir EM; Aref MM; Abdel-Aziz HA
Future Med Chem; 2019 Sep; 11(18):2395-2414. PubMed ID: 31544523
[No Abstract] [Full Text] [Related]
22. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies.
El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA
Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
[TBL] [Abstract][Full Text] [Related]
24. A novel [1,2,4] triazolo [1,5-a] pyrimidine-based phenyl-linked steroid dimer: synthesis and its cytotoxic activity.
Yu B; Shi XJ; Zheng YF; Fang Y; Zhang E; Yu DQ; Liu HM
Eur J Med Chem; 2013 Nov; 69():323-30. PubMed ID: 24077182
[TBL] [Abstract][Full Text] [Related]
25. Antitumor and antimicrobial activities of some hetero aromatic benzofurans derived from naturally occurring visnagin.
El-Nakkady SS; Roaiah HF; El-Serwy WS; Soliman AM; El-Moez SI; Abdel-Rahman AA
Acta Pol Pharm; 2012; 69(4):645-55. PubMed ID: 22876607
[TBL] [Abstract][Full Text] [Related]
26. Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
Lamie PF; El-Kalaawy AM; Abdel Latif NS; Rashed LA; Philoppes JN
Eur J Med Chem; 2021 Mar; 214():113222. PubMed ID: 33545637
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and anticancer evaluation of novel pyrazole, pyrazolo[3,4-d]pyrimidine and their glycoside derivatives.
Nassar IF; El Farargy AF; Abdelrazek FM; Ismail NSM
Nucleosides Nucleotides Nucleic Acids; 2017 Apr; 36(4):275-291. PubMed ID: 28323527
[TBL] [Abstract][Full Text] [Related]
28. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, tumor inhibitory and antioxidant activity of new polyfunctionally 2-substituted 5,6,7,8-tetrahydronaphthalene derivatives containing pyridine, thioxopyridine and pyrazolopyridine moieties.
Hamdy NA; Anwar MM; Abu-Zied KM; Awad HM
Acta Pol Pharm; 2013; 70(6):987-1001. PubMed ID: 24383322
[TBL] [Abstract][Full Text] [Related]
30. 4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity.
Abbas SE; Aly EI; Awadallah FM; Mahmoud WR
Chem Biol Drug Des; 2015 May; 85(5):608-22. PubMed ID: 25318985
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity.
Ali GME; Ibrahim DA; Elmetwali AM; Ismail NSM
Bioorg Chem; 2019 May; 86():1-14. PubMed ID: 30682722
[TBL] [Abstract][Full Text] [Related]
33. Enaminones as building blocks for the synthesis of substituted pyrazoles with antitumor and antimicrobial activities.
Riyadh SM
Molecules; 2011 Feb; 16(2):1834-53. PubMed ID: 21343888
[TBL] [Abstract][Full Text] [Related]
34. Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold.
Elzahabi HSA; Nossier ES; Khalifa NM; Alasfoury RA; El-Manawaty MA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):546-557. PubMed ID: 29482389
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents.
Lukasik PM; Elabar S; Lam F; Shao H; Liu X; Abbas AY; Wang S
Eur J Med Chem; 2012 Nov; 57():311-22. PubMed ID: 23085105
[TBL] [Abstract][Full Text] [Related]
36. Convenient synthesis, characterization, cytotoxicity and toxicity of pyrazole derivatives.
Kamel MM
Acta Chim Slov; 2015; 62(1):136-51. PubMed ID: 25830970
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel benzo[4,5]thiazolo[1,2-a]pyrimidine-3-carboxylate derivatives and biological evaluation as potential anticancer agents.
Nagarapu L; Vanaparthi S; Bantu R; Ganesh Kumar C
Eur J Med Chem; 2013 Nov; 69():817-22. PubMed ID: 24113366
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents.
Holla BS; Mahalinga M; Karthikeyan MS; Akberali PM; Shetty NS
Bioorg Med Chem; 2006 Mar; 14(6):2040-7. PubMed ID: 16310361
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
Chavva K; Pillalamarri S; Banda V; Gautham S; Gaddamedi J; Yedla P; Kumar CG; Banda N
Bioorg Med Chem Lett; 2013 Nov; 23(21):5893-5. PubMed ID: 24060486
[TBL] [Abstract][Full Text] [Related]
40. Preparation of 3-substituted-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET kinase inhibitors.
Dinér P; Alao JP; Söderlund J; Sunnerhagen P; Grøtli M
J Med Chem; 2012 May; 55(10):4872-6. PubMed ID: 22559926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]